WallStreetZenWallStreetZen

NASDAQ: DMRA
Damora Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Damora Therapeutics earnings were -$209.8M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest DMRA earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$200.7M, up 6,307.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DMRA reported annual earnings of -$209.8M, with 878.8% growth.

DMRA earnings history

Current Revenue
$0.0
Current Earnings
-$209.8M
Current Profit Margin
0%

DMRA Return on Equity

Current Company
-307.4%
Current Industry
-31.4%
Current Market
28.9%
DMRA's Return on Equity (-307.4%)... subscribe to Premium to read more.
High Return on Equity Performance

DMRA Return on Assets

Current Company
-279.5%
Current Industry
-9.6%
DMRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DMRA announces earnings.

DMRA Return on Capital Employed

Current Company
-87.24%
Current Industry
-3.7%
DMRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DMRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DMRA-$209.76M-$209.84MN/A$3.98
OCS-$125.34M-$126.87MN/A-$2.42
AMLX-$144.16M-$144.74MN/A-$1.53
TRVI-$42.68M-$42.76MN/A-$0.32
NRIX-$244.84M-$264.46MN/A-$3.05
View Top Biotech Stocks

Damora Therapeutics Earnings Reports & History FAQ

What were Damora Therapeutics's earnings last quarter?

Damora Therapeutics (NASDAQ: DMRA) reported Q4 2025 earnings per share (EPS) of $10.86, up 307.65% year over year. Total DMRA earnings for the quarter were -$200.74 million. In the same quarter last year, Damora Therapeutics's earnings per share (EPS) was -$5.23.

If you're new to stock investing, here's how to buy Damora Therapeutics stock.

Is Damora Therapeutics profitable or losing money?

As of the last Damora Therapeutics earnings report, Damora Therapeutics is currently losing money. Damora Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$209.84 million, a 878.77% increase year over year.

What was DMRA's earnings growth in the past year?

As of Damora Therapeutics's earnings date in Q2 2026, Damora Therapeutics's earnings has grown year over year. DMRA earnings in the past year totalled -$209.84 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.